U.S. Markets
FDA authorizes ZYN ULTRA nicotine pouches following scientific review
StockNow breaking-news AI analysis
FDA authorized ZYN products under modified risk guidelines, while Philip Morris expands production capacity amid rising competition from BAT's Velo and tightening global regulations.
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
